• 238 Citations
  • 7 Scopus h-Index
20132019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Samuel Antwi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences
Telomere Medicine & Life Sciences
Odds Ratio Medicine & Life Sciences
African Americans Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 238 Citations
  • 7 Scopus h-Index
  • 24 Article
  • 1 Chapter
  • 1 Letter
  • 1 Review article

Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA

Hlady, R. A., Zhao, X., Pan, X., Dong Yang, J., Ahmed, F., Antwi, S. O., Giama, N. H., Patel, T., Roberts, L. R., Liu, C. & Robertson, K. D., Jan 1 2019, In : Theranostics. 9, 24, p. 7239-7250 12 p.

Research output: Contribution to journalArticle

Open Access
DNA Methylation
Liver Neoplasms
Hepatocellular Carcinoma
Biomarkers
Genome
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Metformin
Hepatocellular Carcinoma
Joints
Survival
1 Citation (Scopus)

Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status

Antwi, S., Fagan, S. E., Chaffee, K. G., Bamlet, W. R., Hu, C., Polley, E., Hart, S., Shimelis, H., Lilyquist, J., Gnanaolivu, R. D., Mc Williams, R. R., Oberg, A. L., Couch, F. J. & Petersen, G. M., Mar 1 2019, In : Journal of the National Cancer Institute. 111, 3, p. 264-271 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Mutation
Genes
Confidence Intervals
Neoplasms

Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma

Park, J. Y., Luu, H. N., Park, H. Y., Lin, H. Y., Radlein, S., Di Pietro, G., Yeo, C. D., Kim, S. J., Kang, N., Antwi, S., Sexton, W. J., Spiess, P. E., Dickinson, S. & Parker, A., Jan 1 2019, In : Translational Cancer Research. 8, p. S397-S403

Research output: Contribution to journalArticle

Telomere
Renal Cell Carcinoma
Leukocytes
Neoplasms
Odds Ratio
gemcitabine
Cholangiocarcinoma
Cisplatin
Epidemiology
Survival